Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

A new teledermatology system improved access and reduced wait times for skin care.

Vitamin D analogues can significantly help hair regrowth in Alopecia Areata patients.

Scalp psoriasis treatments like strong corticosteroids and vitamin D3 analogues are effective, especially when combined.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib works well and is safe for treating alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Baricitinib is a safe and effective treatment for severe alopecia areata.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Rituximab can cause skin issues, but baricitinib may help improve them.

Abatacept may help some people with alopecia areata regrow hair.

Topical tretinoin 0.025% cream is an effective treatment for Eruptive Vellus Hair Cysts in children.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Systemic retinoids do not increase COVID-19 risk or severity.

Oral alitretinoin can quickly regrow hair in alopecia universalis.